← Open Payments lookup

VERONICA CARRERA: Open Payments

NPI 1902547177 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,284 in 34 payments from 10 companies in 2025. Trend: 2023 $2,388 · 2024 $1,765 · 2025 $1,284

Food & beverage: $1,284
CompanyPaymentsAmount
Madrigal Pharmaceuticals6$461
Lilly USA, LLC5$203
Ipsen Biopharmaceuticals, Inc3$159
Phathom Pharmaceuticals, Inc.2$123
ABBVIE INC.5$92
Janssen Biotech, Inc.4$76
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$58
Gilead Sciences, Inc.3$49
Celltrion USA Inc.2$46
Takeda Pharmaceuticals U.S.A., Inc.1$18

Products named: REZDIFFRA, OMVOH, IQIRVO, VOQUEZNA, TREMFYA, LINZESS, XIFAXAN, VEGZELMA.

Industry payments across TX — which companies pay providers there.